These results taken together not only support our observation in the crystal structure of DUX4HD2-DNADRE, but also suggest DUX4HD1–HD2-DRE interacting motif as a potential therapeutic target for future treatment against B-ALL harboring DUX4/IGH fusion. This evidence concerns the gene DUX4 and acute lymphoblastic leukemia.